Genomic and metabolomic patterns segregate with responses to calcium and vitamin D supplementation

British Journal of Nutrition

Volumn 105, Issue 1, 2011, Pages 71-79

  Elnenaei, Manal O ^a   Chandra, Rama ^a   Mangion, Tina ^a   Moniz, Caje ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Genotyping; Metabolomics; Oestrogen receptor; Vitamin D receptor

Indexed keywords

ADENINE; CALCIUM; CYTOSINE; ESTROGEN RECEPTOR ALPHA; GUANINE; PARATHYROID HORMONE; THYMINE; VITAMIN D; VITAMIN D RECEPTOR;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BONE DENSITY; BONE MASS; CODON; CONTROLLED CLINICAL TRIAL; DIET SUPPLEMENTATION; DNA POLYMORPHISM; DRUG RESPONSE; FEMALE; GENE FREQUENCY; GENE SEGREGATION; GENETIC VARIABILITY; GENOMICS; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; METABOLOMICS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OBSERVATIONAL STUDY; PATTERN RECOGNITION; POSTMENOPAUSE; URINALYSIS; VITAMIN SUPPLEMENTATION;

AGED; AGED, 80 AND OVER; BONE DENSITY; CALCIUM, DIETARY; CASE-CONTROL STUDIES; DIETARY SUPPLEMENTS; ESTROGEN RECEPTOR ALPHA; FEMALE; GENOME; GENOTYPE; HUMANS; INTESTINAL ABSORPTION; MAGNETIC RESONANCE SPECTROSCOPY; METABOLOME; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; PHARMACOGENETICS; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; RECEPTORS, CALCITRIOL; VITAMIN D;

EID: 79951597868     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114510003065     Document Type: Article

References (39)

1. Arvold DS, Odean MJ, Dornfeld MP, et al. (2009) Correlation of symptoms with vitamin D deficiency and symptom response to cholecalciferol treatment: a randomized controlled trial. Endocr Pract 15, 203-212.
2. Teegarden D & Donkin SS (2009) Vitamin D: emerging new roles in insulin sensitivity. Nutr Res Rev 22, 82-92.
3. Artaza JN, Mehrotra R & Norris KC (2009) Vitamin D and the cardiovascular system. Clin J Am Soc Nephrol 4, 1515-1522.
4. Cross HS, Nittke T & Peterlik M (2009) Modulation of vitamin D synthesis and catabolism in colorectal mucosa: a new target for cancer prevention. Anticancer Res 29, 3705-3712.
5. Adami S, Giannini S, Bianchi G, et al. (2009) Vitamin D status and response to treatment in post-menopausal osteoporosis. Osteoporos Int 20, 239-244.
6. Ray NF, Chan JK, Thamer M, et al. (1997) Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation. J Bone Miner Res 12, 24-35. (Pubitemid 27053608)
7. Cummings SR & Melton LJ (2002) Epidemiology and outcomes of osteoporotic fractures. Lancet 359, 1761-1767.
8. World Health Organisation (2003) Prevention and Management of Osteoporosis. World Health Organisation Technical Report Series no. 921. Geneva: WHO.
9. Baldock PA & Eisman JA (2004) Genetic determinants of bone mass. Curr Opin Rheumatol 16, 450-456. (Pubitemid 38803148)
10. Richards JB, Rivadeneira F, Inouye M, et al. (2008) Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study. Lancet 371, 1505-1512.
11. Bruyère O, Malaise O, Neuprez A, et al. (2007) Prevalence of vitamin D inadequacy in European postmenopausal women. Curr Med Res Opin 23, 1939-1944. (Pubitemid 47300393)
12. Bischoff-Ferrari HA, Giovannucci E, Willett WC, et al. (2006) Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 84, 18-28. (Pubitemid 44699167)
13. Dawson-Hughes B, Harris SS & Finneran S (1995) Calcium absorption on high and low calcium intakes in relation to vitamin D receptor genotype. J Clin Endocrinol Metab 80, 3657-3661.
14. Wishart JM, Horowitz M, Need AG, et al. (1997) Relations between calcium intake, calcitriol, polymorphisms of the vitamin D receptor gene, and calcium absorption in premenopausal women. Am J Clin Nutr 65, 798-802. (Pubitemid 27111088)
15. Willing M, Sowers M, Aron D, et al. (1998) Bone mineral density and its change in white women: estrogen and vitamin D receptor genotypes and their interaction. J Bone Miner Res 13, 695-705. (Pubitemid 28163021)
16. Wood RJ & Fleet JC (1998) The genetics of osteoporosis: vitamin D receptor polymorphisms. Annu Rev Nutr 18, 233-258. (Pubitemid 28366867)
17. Ordovas JM & Mooser V (2004) Nutrigenomics and nutrigenetics. Curr Opin Lipidol 15, 101-108. (Pubitemid 38453397)
18. Zeisel SH (2007) Nutrigenomics and metabolomics will change clinical nutrition and public health practice: insights from studies on dietary requirements for choline. Am J Clin Nutr 86, 542-548. (Pubitemid 47435818)
19. Whitfield PD, German AJ & Noble PJ (2004) Metabolomics: an emerging post-genomic tool for nutrition. Br J Nutr 92, 549-555. (Pubitemid 39406637)
20. Lindon JC, Nicholson JK, Holmes E, et al. (2000) Metabonomics: metabolic processes studies by NMR spectroscopy of biofluids combined with pattern recognition. Concepts Magn Reson 12, 289-320.
21. Dvornyk V, Long JR, Xiong DH, et al. (2004) Current limitations of SNP data from the public domain for studies of complex disorders: a test for ten candidate genes for obesity and osteoporosis. BMC Genet 5, 4.
22. Talwar SA, Aloia JF, Pollack S, et al. (2007) Dose response to vitamin D supplementation among postmenopausal African American women. Am J Clin Nutr 86, 1657-1662. (Pubitemid 350232180)
23. Nieves SH, Ralston E, Vásquez B, et al. (2007) Vitamin D receptor Fok1 polymorphism influences response to vitamin D supplementation in postmenopausal African-American women. Int Cong Series 1297, 126-132.
24. Gennari L, Becherini L, Masi L, et al. (1997) Vitamin D receptor genotypes and intestinal calcium absorption in postmenopausal women. Calcif Tissue Int 61, 460-463. (Pubitemid 27528270)
25. Abrams SA, Griffin IJ, Hawthorne KM, et al. (2005) Vitamin D receptor Fok1 polymorphisms affect calcium absorption, kinetics, and bone mineralization rates during puberty. J Bone Miner Res 20, 945-953. (Pubitemid 40712818)
26. Ferrari SL & Rizzoli R (2005) Gene variants for osteoporosis and their pleiotropic effects in aging. Mol Aspects Med 26, 145-167. (Pubitemid 40462024)
27. Somjen D (2007) Vitamin D modulation of the activity of estrogenic compounds in bone cells in vitro and in vivo. Crit Rev Eukaryot Gene Expr 17, 115-147. (Pubitemid 46847186)
28. Lee GS, Choi KC, Han HJ, et al. (2007) The classical and a non-classical pathways associated with NF-kappaB are involved in estrogen-mediated regulation of calbindin-D9k gene in rat pituitary cells. Mol Cell Endocrinol 277, 42-50.
29. Colin EM, Uitterlinden AG, Meurs JB, et al. (2003) Interaction between vitamin D receptor genotype and estrogen receptor alpha genotype influences vertebral fracture risk. J Clin Endocrinol Metab 88, 3777-3784. (Pubitemid 37034528)
30. Long J, Liu P, Zhang Y, et al. (2003) Interaction effects between estrogen receptor alpha gene, vitamin D receptor gene, age, and sex on bone mineral density in Chinese. J Hum Gene 48, 514-519. (Pubitemid 37442800)
31. Schwartz B, Smirnoff P, Shany S, et al. (2000) Estrogen controls expression and bioresponse of 1,25-dihydroxyvitamin D receptors in the rat colon. Mol Cell Biochem 203, 87-93. (Pubitemid 30111780)
32. Carling T, Ridefelt P, Hellman P, et al. (1997) Vitamin D receptor polymorphisms correlate to parathyroid cell function in primary hyperparathyroidism. J Clin Endocrinol Metab 82, 1772-1775. (Pubitemid 127495184)
33. Carling T, Kindmark A, Hellman P, et al. (1995) Vitamin D receptor genotypes in primary hyperparathyroidism. Nat Med 1, 1309-1311.
34. Yokoyama K, Shigematsu T, Kagami S, et al. (2001) Vitamin D receptor gene polymorphism detected by digestion with Apa I influences the parathyroid response to extracellular calcium in Japanese chronic dialysis patients. Nephron 89, 315-320. (Pubitemid 34701765)
35. Cusack S & Cashman KD (2003) Impact of genetic variation on metabolic response of bone to diet. Proc Nutr Soc 62, 901-912. (Pubitemid 38004987)
36. Miyao M, Morita H, Hosoi T, et al. (2000) Association of methylenetetrahydrofolate reductase (MTHFR) polymorphism with bone mineral density in postmenopausal Japanese women. Calcif Tissue Int 66, 190-194. (Pubitemid 30091759)
37. Abrahamsen B, Madsen JS, Tofteng CL, et al. (2003) A common methylenetetrahydrofolate reductase (C677T) polymorphism is associated with low bone mineral density and increased fracture incidence after menopause: longitudinal data from the Danish osteoporosis prevention study. J Bone Miner Res 18, 723-729. (Pubitemid 36899322)
38. Frost ML, Blake GM & Fogelman I (2000) Can the WHO criteria for diagnosing osteoporosis be applied to calcaneal quantitative ultrasound? Osteoporos Int 11, 321-330. (Pubitemid 30417185)
39. von Elm E, Altman DG, Egger M, et al. (2007) STROBE initiative. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 370, 1453-1457.